Arisawa Mfg. Co., Ltd. (TYO:5208)
Japan · Delayed Price · Currency is JPY 1,568.00
+18.00 (1.16%)
Aug 1, 2025, 3:30 PM JST
Elevation Oncology Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 5,263 | 2,072 | 3,902 | 4,965 | 3,516 | Upgrade |
Depreciation & Amortization | 2,122 | 2,206 | 2,290 | 2,170 | 2,107 | Upgrade |
Loss (Gain) From Sale of Assets | 8 | 20 | 15 | 23 | 75 | Upgrade |
Loss (Gain) From Sale of Investments | -2 | -678 | -1,289 | -989 | -7 | Upgrade |
Loss (Gain) on Equity Investments | - | 47 | -19 | -15 | 46 | Upgrade |
Other Operating Activities | -426 | -982 | -1,468 | 980 | -4,825 | Upgrade |
Change in Accounts Receivable | 117 | -2,875 | 3,363 | 1,597 | 985 | Upgrade |
Change in Inventory | -2,920 | 955 | -1,328 | -1,486 | -799 | Upgrade |
Change in Accounts Payable | 542 | 1,994 | -983 | -1,160 | -446 | Upgrade |
Change in Other Net Operating Assets | -156 | 460 | -1,012 | -184 | -42 | Upgrade |
Operating Cash Flow | 4,548 | 3,219 | 3,471 | 5,901 | 610 | Upgrade |
Operating Cash Flow Growth | 41.29% | -7.26% | -41.18% | 867.38% | -87.39% | Upgrade |
Capital Expenditures | -2,210 | -3,544 | -4,324 | -1,907 | -1,908 | Upgrade |
Sale of Property, Plant & Equipment | 4 | 2 | 5 | 10 | 1 | Upgrade |
Divestitures | - | 245 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -39 | -235 | -50 | -99 | -75 | Upgrade |
Investment in Securities | 149 | 2,440 | 4,954 | 4,908 | 3,567 | Upgrade |
Other Investing Activities | - | 5 | -69 | -40 | -30 | Upgrade |
Investing Cash Flow | -2,076 | -1,061 | 508 | 2,869 | 1,567 | Upgrade |
Short-Term Debt Issued | - | 111 | 1,403 | - | - | Upgrade |
Long-Term Debt Issued | 2,627 | 3,221 | 1,184 | 1,269 | 1,681 | Upgrade |
Total Debt Issued | 2,627 | 3,332 | 2,587 | 1,269 | 1,681 | Upgrade |
Short-Term Debt Repaid | -460 | - | - | -324 | -1,281 | Upgrade |
Long-Term Debt Repaid | -3,285 | -3,005 | -1,578 | -835 | -514 | Upgrade |
Total Debt Repaid | -3,745 | -3,005 | -1,578 | -1,159 | -1,795 | Upgrade |
Net Debt Issued (Repaid) | -1,118 | 327 | 1,009 | 110 | -114 | Upgrade |
Issuance of Common Stock | 30 | 23 | 348 | 34 | 50 | Upgrade |
Repurchase of Common Stock | -122 | - | -748 | -82 | - | Upgrade |
Dividends Paid | -2,723 | -3,641 | -3,001 | -1,463 | -996 | Upgrade |
Other Financing Activities | -153 | -124 | -180 | -2,641 | -4,643 | Upgrade |
Financing Cash Flow | -4,086 | -3,415 | -2,572 | -4,042 | -5,703 | Upgrade |
Foreign Exchange Rate Adjustments | 286 | 421 | 235 | 677 | 287 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 1 | - | -1 | 2 | Upgrade |
Net Cash Flow | -1,328 | -835 | 1,642 | 5,404 | -3,237 | Upgrade |
Free Cash Flow | 2,338 | -325 | -853 | 3,994 | -1,298 | Upgrade |
Free Cash Flow Margin | 4.69% | -0.77% | -2.00% | 9.27% | -2.79% | Upgrade |
Free Cash Flow Per Share | 70.32 | -9.80 | -25.75 | 119.81 | -38.95 | Upgrade |
Cash Interest Paid | 196 | 205 | 149 | 135 | 162 | Upgrade |
Cash Income Tax Paid | 559 | 1,016 | 1,588 | -889 | 4,970 | Upgrade |
Levered Free Cash Flow | 789.38 | -1,303 | -1,362 | 2,888 | -2,513 | Upgrade |
Unlevered Free Cash Flow | 908.13 | -1,177 | -1,266 | 2,963 | -2,444 | Upgrade |
Change in Net Working Capital | 2,023 | 531 | 574 | -723 | 4,517 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.